The flavour and food ingredients industry is changing. Leading players once competed on scale and portfolio breadth, sustained by heavy R&D spending and acquisitive expansion. Priorities have since shifted: the emphasis now falls on deeper customer co-development, targeted investment in high-growth markets, and more precisely directed R&D.
Many of the industry’s leading companies are adopting similar operational, localisation, and divestment strategies, producing a competitive landscape that is more focused, technically sophisticated, and geographically expansive than it was five years ago.
This article draws on recent reports from leaders such as Kerry, Givaudan, Symrise, dsm-firmenich, and IFF to examine six structural trends that are reshaping the sector and analyse what the transformation means for manufacturers, investors, and the ingredient companies themselves.
The flavour and food ingredients industry at a glance
The flavour and food ingredients industry covers companies that supply flavour systems, functional actives, bioprocessed ingredients, and nutritional components to food, beverage, and pharmaceutical manufacturers. Their commercial model is typically built around blending multiple ingredients into unique products, often tailored to, or co-developed with, specific target markets.
The sector is large and growing. The global flavours market alone is estimated at USD 18–20bn, and is growing at roughly 5% per annum. The broader speciality food ingredient market, which covers texturants, proteins, functional actives, cultures, enzymes, and flavours, is estimated to be above USD 100bn. Demand is driven by the growth and premiumisation of emerging markets, as well as regulatory pressure and an ageing population in established markets.
Six structural trends characterise the current period.
- Operational efficiency: firms are rationalising the sprawling production networks and overlapping cost bases left by decades of acquisition.
- R&D investment: spending on production technologies and operational capabilities has risen sharply.
- Health and wellness: demographic and consumer trends are eroding the old boundary between flavour and nutrition suppliers.
- Portfolio focus: companies are divesting non-core businesses to concentrate capital where technical expertise and customer relationships are strongest.
- Geographic localisation: investment is moving into high-growth markets in Asia-Pacific, the Middle East, and Africa, with capabilities tailored to regional preferences and regulations.
- ESG maturation: organisations are cutting food waste and aligning sustainability reporting with the European Sustainability Reporting Standards (ESRS).
1. Structural efficiency and supply chain rationalisation
The sector dynamic
A decade of expansion via acquisition has left the sector’s largest players with complex, multi-layered operating structures. IFF alone completed more than 20 acquisitions between 2010 and 2022, culminating in the USD 26bn merger with DuPont Nutrition & Biosciences in 2021, the largest transaction in the sector’s history. The portfolios built through those acquisitions are now being deliberately pruned. The acquisition era had sound strategic logic; it built capabilities and reach faster than organic growth could, but integrating large, separately run businesses has left overlapping infrastructure, duplicated functions, and misaligned manufacturing processes.
By contrast, the current period is marked by the systematic dismantling of that legacy. Structural efficiency programmes are now standard practice across the sector’s leading organisations. These programmes usually involve consolidating sites, digitalising production systems, centralising procurement, and reducing headcount. The impact of these programmes can be seen in EBITDA figures. For instance, Symrise’s ONE SYM programme has delivered an EBITDA margin of 21.9% as well as cumulative savings of approximately EUR 100mn, while Kerry’s Accelerate 2.0 programme is targeting an EBITDA margin of 19–20% by 2028.
2. R&D investment and the reformulation imperative
The sector dynamic
R&D spending is high among the leading tier and concentrated in three domains:
- Fermentation and bioprocessing: producing natural, clean-label ingredients at commercial scale.
- Plant-based protein and texture systems: making plant-derived proteins match the taste, and texture of animal-derived alternatives.
- Digital and intelligence applications: enabling faster, more precise co-development with customers.
R&D converging on these three domains signals a collective judgement about where the most commercially valuable innovation opportunities lie over the next five to ten years. Companies that do not invest at scale in at least one of these areas risk lagging behind.
The reformulation demands facing food and beverage manufacturers are growing in complexity . This is compounded by consumer demand for functional nutrition and the technical requirements of plant-based product development. Meeting these demands requires formulation science and application expertise that traditional commodity suppliers cannot provide. As a result, the most valuable supplier relationships in the sector are shifting from arm’s-length transactional supply chains toward extended co-development partnerships.
In this environment, the ability of an ingredient supplier to combine genuine formulation science, proprietary biotechnology platforms, and precise consumer insights is likely to be a decisive differentiator.
3. Health, wellness, and the expansion of functional nutrition
The sector dynamic
The old distinction between companies focused on taste and flavour science and those focused on nutritional actives and functional ingredients is breaking down. Flavour-led companies like Givaudan and IFF are deepening their nutritional science capabilities, while nutrition-focused companies such as dsm-firmenich are moving aggressively into taste and sensory science. The result is a competitive landscape in which the ability to deliver in both taste performance and nutritional benefit is fast becoming the expected standard.
Evidence of strengthening demand for functional and health-positioned ingredients is visible across all major demographic segments. Ageing populations in developed markets are driving demand for ingredients that support longevity, including cognitive function, gut health, joint health, and immune support. Younger consumers in developed and emerging markets are increasingly choosing products for their nutritional and functional benefits such as protein levels.
Reinforcing these consumer trends is regulatory pressure on nutrient content and growing investor scrutiny.
The response across the sector’s leading companies is consistent. Revenue from health and functional ingredient categories is growing faster than from traditional flavour and taste categories within every major portfolio. For instance, Givaudan’s Health and Functional segment grew from around one-third to roughly two-fifths of Taste and Wellbeing divisional sales between 2020 and 2025, and the same directional shift is evident across the peer group.
Growing demand for functional ingredients means companies must now offer demonstrable expertise across taste, nutrition, and health. The transition demands sustained R&D investment, targeted acquisitions, and, in many cases, deep organisational realignment. Many leading ingredient producers have already acquired specialist companies, primarily in probiotics, clinical nutrition, and plant proteins, absorbing several of the industry’s most attractive targets. For companies that have not yet made equivalent moves, the strategic cost of delay is rising, and building equivalent capabilities organically will prove progressively more challenging as the pool of acquisition candidates shrinks.
4. Portfolio rationalisation and the focused platform model
For a decade, leading companies built scale and breadth through acquisition, expanding from core ingredient categories into adjacent segments. The current period is marked by a deliberate reversal of that pattern.
The strategic logic of this shift is clear. Diversification-led M&A creates scale and opens new markets, but it also disperses management attention, complicates capital allocation, and produces portfolios that are difficult to explain coherently to customers and investors. The businesses now being divested are not necessarily unprofitable. Instead, they are structurally misaligned with the focused food, beverage, and health ingredient propositions around which the leading companies are converging. By exiting these positions, ingredient companies can narrow their competitive scope and concentrate resources in the remaining categories.
The scale of divestment activity in 2024 and 2025 reflects this logic in practice. Kerry completed the sale of Kerry Dairy Ireland in 2024, marking the end of its transformation into a pure-play taste and nutrition company. IFF divested its Pharma Solutions operation in early 2025. dsm-firmenich agreed to the sale of its Animal Nutrition and Health division to CVC Capital Partners in February 2026. Symrise divested its Aqua Feed business in 2025 and is preparing the divestment of its Terpene Ingredients operation. Each transaction produces the same structural outcome: a simpler portfolio, a leaner organisation, and a sharper competitive identity.
Notably, the capital released by these divestments is not usually being redeployed into new categories. Kerry returned EUR 557mn to shareholders via buyback in 2024, with a further EUR 300mn programme approved in 2025. dsm-firmenich returned over EUR 1bn to shareholders following its post-merger restructuring. This pattern reflects a clear management preference for capital discipline and shareholder returns over further expansion.
There are, however, notable divergences from this pattern. Givaudan is pursuing an acquisition-led expansion strategy, using a strong free cash flow profile to build capability in adjacent high-growth categories, such as nutrition and beauty. Similarly US group Ingredion recently struck a deal to buy Britain’s Tate & Lyle for £2.7 billion in cash as it seeks to consolidate its position as a focused provider of specialty food ingredients.
5. Geographic localisation and emerging market investment
Many of the flavour and food ingredients industry’s leading companies have reached a consensus: physical presence and local formulation capability are prerequisites for meaningful participation in high-growth markets. The established model of serving emerging markets from centralised R&D and manufacturing hubs in Europe and North America is no longer adequate. The most commercially significant development in the specialty ingredient sector is the rise of ingredient suppliers and food manufacturers working together to co-develop products from concept through to launch. This inherently requires local technical resources close to the customer, and so, innovation centres, application laboratories, and customer experience facilities are being established across priority markets. For instance, Kerry opened new centres in Dubai, South Jakarta, Frankfurt, Egypt, and Rwanda in 2025, bringing its global innovation network to more than 60 locations.
Beyond customer-facing infrastructure, the companies are also extending actual manufacturing capacity in these regions, and for two distinct reasons. The first is supply chain efficiency, since producing near the customer cuts freight, lead time, currency exposure, and tariff cost. The second is regulatory, as many emerging markets impose local-content rules, such as country-specific certifications, halal or kosher compliance requirements, or import restrictions, which make local production preferable or even mandatory.
For investors, the locations of new innovation centres and manufacturing facilities may prove illustrative as they signal which markets the industry expects future revenue growth to come from. The payoff, however, is slow. These initiatives often build customer relationships and product pipelines long before they generate sales, and so, commercial opportunities may take time to mature.
6. ESG maturation and the sustainability imperative
On Scope 1 and 2 emissions, progress within the flavour and food ingredients industry has been substantial, with reductions of 50% or more against baseline years frequently being reported. For instance, Kerry has cut emissions by 52% against its 2017 baseline; Givaudan has held CDP Climate A ratings for seven consecutive years and converted its entire electricity supply to renewables; and Symrise has embedded carbon targets in executive board remuneration, with progress independently verified against Science Based Targets initiative (SBTi) criteria.
The sector is embedding waste reduction into its product development. Several examples illustrate this; Givaudan’s Green Banana Powder uses agricultural co-streams that would otherwise be discarded, dsm-firmenich’s MaxirenEVO coagulant improves cheese yield and so reduces the raw milk required per unit; and Kerry’s natural cocoa replacement system uses less than half the raw cocoa input of conventional systems.
ESG reporting is now measurable and commercially consequential. Institutional investors are undertaking more rigorous ESG due diligence, and the European Sustainability Reporting Standards (ESRS) regime is raising the bar for disclosure quality and auditor assurance. Givaudan arguably holds the most comprehensive reporting credentials in the sector, combining GRI, SASB, TCFD, TNFD, SFDR and the Swiss Climate Ordinance with independent auditor assurance. Others are not far behind, and assurance standards are rising across the industry. Kerry publishes a 76-page Sustainability Statement with external practitioner sign-off on KPIs. dsm-firmenich completed its first full ESRS compliance cycle in 2024 with statutory auditor assurance.
Competing in a converging sector
The structural trends examined in this paper are not independent. Each accelerates the others, and that mutual reinforcement is what makes their simultaneous occurrence transformative. The next phase of competition will be decided by how effectively each company can convert R&D spending into commercially deployed solutions, how quickly they can build genuine local capability in high-growth markets, and how deeply they embed themselves in the reformulation and sustainability programmes of the food manufacturers they serve.
At Farrelly Mitchell, our food and beverage consultants provide strategic, technical, and commercial expertise to help food and beverage operators make informed decisions and achieve sustainable growth. Whether the priority is to gain market insights, advance M&A strategy, enter high-growth markets, or improve ESG reporting and sustainability assurance, we help ingredient suppliers, manufacturers, and investors understand their business and markets and discover how best to position themselves. With a proven track record across the entire flavour and food and ingredients value chain, we combine local market insights with global best practices to optimise your operations, address complex challenges, and capitalise on emerging opportunities. Contact our experts today to discuss how we can support your business’ continued growth and profitability.
